Close Menu

University of Pittsburgh

This article has been updated from a previous version to clarify information about ongoing efforts to resolve the discordant results of the two studies.
By Ben Butkus

Originally published Oct. 31.
The University of Pittsburgh Medical Center announced last week that it will invest around $300 million to build a new research facility focused on personalized treatments for cancer, viral diseases, and age-related conditions.

The University of Pittsburgh Medical Center said today that it plans to invest $294 million in building a research center in Pittsburgh that will focus on personalized medicine and the biology of cancer and aging.

Pairings: Oct 19, 2011

Premium

The University of Pittsburgh has awarded J. Craig Venter the Dickson Prize for his efforts in genome sequencing, including leading efforts to sequence the first human genome and creating a living bacteria cell with synthetic DNA.

The researchers will use an NIH grant to seek protein biomarkers in the blood to predict clinical outcomes of traumatic brain injury.

Paired Ends: Aug 2, 2011

Premium

Craig Venter

Biosigma, Canon, Advanced Liquid Logic, Duke University, Qiagen, and others win US patents.

The company's early access-program for its SmartChip system includes eight new university and corporate customers.

The early-access agreements provide Wafergen with an undisclosed amount of revenue, and are expected to help validate the SmartChip platform prior to its planned launch later this year.

The research provides some short-term consumables revenue for Wafergen and validates its SmartChip real-time PCR system in advance of its full commercial launch, a company executive said.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.